A PYMNTS Company

Chile: TDLC picks up lab collusion case

By  |  November 12, 2018

Chile´s Tribunal for the Defense of Free Competition (TDLC) picked up this Friday November 9 the request for probing a possible case of collusion filed by the National Economic Prosecutor’s Office (FNE) against Biosano laboratories, Fresenius Kabi Chile and its subsidiary Sanderson, for allegedly forming a cartel affecting bids called by the Supply Center for the National System of Health Services (Cenabast).

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The TDLC imposed on Sanderson and Fresenius an obligation to adopt a free competition compliance program for five years in accordance with the “Guide to Compliance Programs of Free Competition Regulations”, prepared by the FNE. This is added to the fines for 30 thousand Annual Tax Units (UTA, equivalent to US$25.6 million) to Laboratorios Sanderson and 2,463 UTA, equivalent to US $2.1 million, to Fresenius Kabi Chile, while Biosano escaped fines by joining the agency´s leniency program.

    In its ruling, the TDLC noted that “the evidence cited above shows that the accused had agreed to affect bidding processes convened by Cenabast for the provision of ampoules, from at least 1999 to February 2013.” This is the sixth time that the FNE publicly presents the TDLC with a case that incorporates the leniency compensation mechanism, available in Chile since 2009.

    Full Content: Estrategia
    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.